COLLPLANT BIOTECHNOLOGIES LT (CLGN) Stock Income Statement
NASDAQ:CLGN - Nasdaq - IL0004960188 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 515.00K | 10.96M | 300.00K | 15.64M | 6.14M | |||
| Cost Of Goods | 1.34M | 1.13M | 100.00K | 1.64M | 3.00M | |||
| Gross Profit | -824.00K | 9.83M | 200.00K | 14.00M | 3.14M | |||
| Operating Expenses | 16.14M | 16.48M | 17.00M | 13.57M | 8.74M | |||
| Research and Development | 10.52M | 10.48M | 10.26M | 7.63M | 3.66M | |||
| Selling, General, and Administrative Expenses | 5.63M | 6.00M | 6.74M | 5.94M | 4.62M | |||
| Operating Income | -16.96M | -6.65M | -16.80M | 440.00K | -5.60M | |||
| Interest Income/Expense | 659.00K | 503.00K | 180.00K | 200.00K | -140.00K | |||
| Other Income/Expense | -17.00K | -10.00K | -10.00K | -30.00K | -30.00K | |||
| Non Recurring Items | -286.00K | -866.00K | -300.00K | -370.00K | N/A | |||
| Income Before Taxes | -16.61M | -7.02M | -16.93M | 240.00K | -5.77M | |||
| Net Income | -16.61M | -7.02M | -16.93M | 240.00K | -5.77M | |||
| EBITDA | -15.93M | -5.54M | -15.72M | 1.21M | -4.94M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.45 | -0.62 | -1.53 | 0.02 | -0.84 | |||
| Non GAAP EPS | -1.46 | -0.46 | -1.53 | -0.01 | -0.79 | |||
| Statistics | ||||||||
| Gross Profit Margin | -160.00% | 89.73% | 66.67% | 89.51% | 51.14% | |||
| Profit Margin | -3225.05% | -64.05% | -5643.33% | 1.53% | -93.97% | |||
| Operating Profit Margin | -3294.17% | -60.64% | -5600.00% | 2.81% | -91.21% | |||
All data in USD